STM Journals Peer-reviewed research from Consortium e-Learning Network

Research and Reviews: A Journal of Pharmacology Review Article

Strategies in the Battle against Recurrent UTIs: A Brief Overview

  1. Adinarayana Andy Weatherwax Family Pharmacies Inc Spring Arbor
  2. Divya Andy Consultant
  3. Aman Suresh Tharayil Department of Pharmacy Practice, Sandip Institute of Pharmaceutical Sciences, Nashik
  4. N V L Sirisha Mulukuri Nitte College of Pharmaceutical Sciences

Abstract

Recurrent urinary tract infections (UTIs) present a serious medical issue, and such conditions can disappoint those affected. They are uncomfortable, but a difficulty arises because treating such conditions with antibiotics comes with the risk of antibiotic overuse. This summary will evaluate the measures incorporated in treating frequent UTIs in the contemporary world. These measures include taking antibiotics regularly to prevent infections and alternatives to antibiotics such as probiotics, cranberry extract, and D-mannose. Changes in lifestyle and behavior, such as drinking more fluids and practicing better hygiene etiquette, also help decrease the chances of repeated UTIs. There is also promising progress on the UTI vaccines and possibilities of individual-based medicine in treatment approaches improvement in the future. With these and other methods, it should be possible to curb the chances of reinfection while minimizing the use of antibiotics in the treatment, which is a beneficial strategy considering the issue of global antibiotic resistance.

Keywords

References (12)

  1. Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary tract infections: the current scenario and prospects. Pathogens. 2023;12(4):623.
  2. Santos M, Mariz M, Tiago I, Martins J, Alarico S, Ferreira P. A review on urinary tract infections diagnostic methods: Laboratory-based and point-of-care approaches. Journal of Pharmaceutical and Biomedical Analysis. 2022;219:114889. doi:10.1016/j.jpba.2022.114889
  3. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84.
  4. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases. 2011;52(5):e103-e120. doi:10.1093/cid/ciq257
  5. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182(4):1177-82.
  6. Ventola CL. The antibiotic resistance crisis: Part 1: Causes and threats. P T. 2015;40(4):277-83.
  7. Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: A randomized clinical trial. World J Urol. 2014;32(1):79-84.
  8. Porru D, Parmigiani A, Tinelli C, Barletta D, Choussos D, Tudino D, et al. Oral D-mannose in recurrent urinary tract infections. Urol Int. 2010;84(4):450-4.
  9. Wang CH, Fang CC, Chen NC, Liu SS, Yu PH, Wu TY, et al. Cranberry-containing products for prevention of urinary tract infections: A meta-analysis. Arch Intern Med. 2012;172(13):988-96.
  10. Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2016;(7).
  11. Wagenlehner FM, Ballarini S, Pilatz A, Weidner W. Immunoactive prophylaxis of recurrent urinary tract infections: A meta-analysis. Int J Antimicrob Agents. 2011;38(2):102-10.
  12. Barrons R, Tassone C. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: A review. Clin Ther. 2008;30(3):453-68.
Support